Target intelligence / Profile preview

1→3-beta-D-glucan synthase

Molecular classification
Enzyme, Glycosyltransferase, GT48
01

Overview

1→3-beta-D-glucan synthase is a membrane-bound enzyme complex responsible for synthesizing (1,3)-β-D-glucan, a major structural polysaccharide in the fungal cell wall. This enzyme is essential for fungal viability and serves as a key pharmacological target for antifungal drugs such as echinocandins and ibrexafungerp. It catalyzes the polymerization of UDP-glucose to form linear (1,3)-β-D-glucan chains, which provides rigidity and integrity to the fungal cell wall. The main catalytic subunit in S. cerevisiae is Fks proteins (FKS1/FKS2).

Other names
GS-IIParamylon synthetaseCallose synthaseFks
02

Mechanism of action

Noncompetitively inhibits the enzyme by binding to specific regions on Fks subunits, disrupting cell wall synthesis

03

Biological functions

Cell wall biosynthesisMorphogenesisStress responseCatalyzes the polymerization of UDP-glucose to form linear (1,3)-β-D-glucan chains
04

Disease associations

Infection
05

Interacting drugs

Echinocandins (caspofungin, anidulafungin, micafungin)

1 more in the full profile.

Beyond the preview

Go deeper on 1→3-beta-D-glucan synthase.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 1→3-beta-D-glucan synthase.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call